Increases in cortical glutamate concentrations in transgenic amyotrophic lateral sclerosis mice are attenuated by creatine supplementation

Journal of Neurochemistry

Volumn 77, Issue 2, 2001, Pages 383-390

  Andreassen, Ole A ^a   Jenkins, Bruce G ^a   Dedeoglu, Alpaslan ^a   Ferrante, Kimberly L ^a   Bogdanov, Mikhail B ^a   Kaddurah Daouk, Rima ^b   Flint Beal, M ^a,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Avicena Group   (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Creatine; Glutamate; Glutamate transport; Magnetic resonance spectroscopy; Oxidative damage

Indexed keywords

2,4 PYRROLIDINECARBOXYLIC ACID; CREATINE; GLUTAMATE TRANSPORTER; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENERGY TRANSFER; GENE MUTATION; LONGEVITY; MALE; MICRODIALYSIS; MOTOR PERFORMANCE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL;

AMINO ACID TRANSPORT SYSTEM X-AG; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; BODY WEIGHT; BRAIN CHEMISTRY; CREATINE; DICARBOXYLIC ACIDS; DISEASE MODELS, ANIMAL; EXCITATORY AMINO ACID AGONISTS; GLUTAMIC ACID; GLUTAMINE; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MICE; MICE, TRANSGENIC; MICRODIALYSIS; MOTOR ACTIVITY; MOTOR NEURON DISEASE; N-METHYLASPARTATE; NEUROTRANSMITTER UPTAKE INHIBITORS; OXIDATIVE STRESS; PSYCHOMOTOR PERFORMANCE; PYRROLIDINES; SUPEROXIDE DISMUTASE;

ANIMALIA; MUS MUSCULUS;

EID: 0035051503     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2001.00188.x     Document Type: Article

References (42)

1. Elevated cortical extracellular fluid glutamate in transgenic mice expressing human mutant (G93A) Cu/Zn superoxide dismutase
2. Partial deficiency of manganese superoxide dismutase exacerbates a transgenic mouse model of ALS
3. Protein oxidative damage in a transgenic mouse model of familial amyotrophic lateral sclerosis
4. Mutations in the glutamate transporter EAAT2 gene do not cause abnormal EAAT2 transcripts in amyotrophic lateral sclerosis
5. Elevated 'hydroxyl radical' generation in vivo in an animal model of amyotrophic lateral sclerosis
6. Glutamate transporter gene expression in amyotrophic lateral sclerosis motor cortex
7. Amyotrophic lateral sclerosis: Recent insights from genetics and transgenic mice
8. ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease and SOD1-containing inclusions
9. Glutamate uptake is decreased tardively in the spinal cord of FALS mice
10. AMPA exposures induce mitochondrial Ca(2+) overload and ROS generation in spinal motor neurons in vitro
11. Increased 3-nitrotyrosine and oxidative damage in mice with a human Cu, Zn superoxide dismutase mutation
12. Neuroprotective effects of creatine in a transgenic mouse model of Huntington's disease
13. ALS-linked Cu/Zn-SOD mutation impairs cerebral synaptic glucose and glutamate transport and exacerbates ischemic brain injury
14. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation
15. Glutamate transporter EAAT2 splice variants occur not only in ALS, but also in AD and controls
16. Nonlinear decrease over time in N-acetyl aspartate levels in the absence of neuronal loss and increases in glutamine and glucose in transgenic Huntington's disease mice
17. 4-Hydroxynonenal, an aldehydic product of membrane lipid peroxidation, impairs glutamate transport and mitochondrial function in synaptosomes
18. Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis
19. ALS-linked Cu/Zn-SOD mutation increases vulnerability of motor neurons to excitotoxicity by a mechanism involving increased oxidative stress and perturbed calcium homeostasis
20. Aberrant RNA processing in a neurodegenerative disease: The cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis
21. The roles of free radicals in amyotrophic lateral sclerosis: Reactive oxygen species and elevated oxidation of protein, DNA, and membrane phospholipids
22. Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's disease
23. The EAAT2 (GLT-1) gene in motor neuron disease: Absence of mutations in amyotrophic lateral sclerosis and a point mutation in patients with hereditary spastic paraplegia
24. Differential effects of creatine depletion on the regulation of enzyme activities and on creatine-stimulated mitochondrial respiration in skeletal muscle, heart, and brain
25. Oxidative damage to brain proteins, loss of glutamine synthetase activity, and production of free radicals during ischemia/reperfusion- induced injury to gerbil brain
26. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis
27. Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis
28. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis
29. Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity
30. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis
31. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate
32. Glutamate potentiates the toxicity of mutant Cu/Zn-superoxide dismutase in motor neurons by postsynaptic calcium-dependent mechanisms
33. Role of the creatine/phosphocreatine system in the regulation of mitochondrial respiration
34. Glutamate triggers preferential Zn2+ flux through Ca2+ permeable AMPA channels and consequent ROS production
35. Reduction of G1uR2 RNA editing, a molecular change that increases calcium influx through AMPA receptors, selective in the spinal ventral gray of patients with amyotrophic lateral sclerosis
36. Mild kainate toxicity produces selective motoneuron death with marked activation of CA (2+)-permeable AMPA/kainate receptors
37. Peroxynitrite inhibits glutamate transporter subtypes
38. SOD1 mutants linked to amyotrophic lateral sclerosis selectively inactivate a glial glutamate transporter
39. Glutamate uptake inhibition by oxygen free radicals in rat cortical astrocytes
40. Calcium-permeable alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors: A molecular determinant of selective vulnerability in amyotrophic lateral sclerosis
41. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria
42. Phosphocreatine-dependent glutamate uptake by synaptic vesicles